A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial.
| Image |  |
|---|---|
| Description | scientific article published on 24 May 2017 |
| Author/s |
author: Manvir K Hayer Rick P Steeds Jonathan N Townend Charles J. Ferro |
| Publication date | May 24, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |